Lactose Intolerance Clinical Trial
Official title:
Prospective, Open-Label, Randomized, Two-Period, Two-Sequence, Crossover Study Comparing RP-G28 Administered in the Fasted State and the Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Volunteers
Randomized, open-label, 2-period, 2-sequence, crossover study to evaluate the effect of a standard meal on the pharmacokinetic (PK) profile of orally administered RP-G28.
This randomized, open-label, 2-period, 2-sequence, crossover study is designed to evaluate the effect of a standard meal on the pharmacokinetic (PK) profile of orally administered RP-G28, which is being developed for the treatment of lactose intolerance. The study consists of a screening visit (during the interval from Day -21 to Day -3), baseline/check-in to the clinical research unit (Day -2 to Day -1), 2 treatment periods (Day 1 and Day 3), a 48-hour washout between doses, check-out from the clinical research unit (Day 4), and 1 follow-up phone call conducted 7 to 10 days after the final dose of the study drug (i.e., during the interval from Day 10 to Day 13). The duration of subject study participation is approximately 5 weeks. Plasma samples for PK analysis will be taken at specified timepoints from 24 hours prior to each dose through 24 hours after each dose. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
Completed |
NCT02518295 -
β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion
|
N/A | |
Completed |
NCT00599859 -
Effects of Lactose on Fecal Microflora
|
N/A | |
Completed |
NCT02636413 -
Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance
|
Phase 4 | |
Completed |
NCT02406469 -
Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior
|
Phase 4 | |
Terminated |
NCT00247806 -
Prevalence of Lactose Intolerance Following Stem Cell Transplantation
|
Phase 1 | |
Completed |
NCT03814668 -
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution
|
N/A | |
Completed |
NCT03860051 -
Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
|
||
Not yet recruiting |
NCT06107088 -
Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance
|
N/A | |
Completed |
NCT02703987 -
HYBRID: Hydrogen Breath Test in Lactose Digestion
|
N/A | |
Completed |
NCT00395954 -
Amount of Lactose Causing Symptoms in Lactose Intolerant People
|
Phase 0 | |
Completed |
NCT01593800 -
The Effect of Probiotics on Lactose Intolerance
|
N/A | |
Completed |
NCT04164394 -
Effect of I31 Probiotic on Lactose Intolerance
|
N/A | |
Recruiting |
NCT05668468 -
A Bifido Bacteria to Improve Lactose Digestion and Tolerance
|
N/A | |
Recruiting |
NCT02085889 -
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
|
||
Completed |
NCT03597516 -
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
Not yet recruiting |
NCT03563859 -
Evaluation of Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
Completed |
NCT02171403 -
Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls
|
N/A | |
Completed |
NCT01145586 -
A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia
|
Phase 3 | |
Completed |
NCT02902016 -
Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies
|
N/A |